Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 9/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 9/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 8/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 8/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CPB1 | P15086 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18963329 | 0.74 | NPC1 (0.42) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL18963354 | 0.71 | ALDH1A1 (0.43) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL509970 | 0.68 | POLB (0.44) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL4558468 | 0.67 | KDM1A (0.48) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL13380972 | 0.67 | POLB (0.47) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL28078911 | 0.67 | POLB (0.38) | NPSR1KDM4ECHRM5CHRM3CHRM2 | |
| SCHEMBL5176857 | 0.66 | NPC1 (0.40) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL17863581 | 0.66 | MAPK1 (0.37) | NPC1KMT2ACYP2C19MEN1MAPK1 | |
| SCHEMBL6376132 | 0.65 | NPC1 (0.50) | NPC1NPSR1KDM4ECHRM5CHRM3 | |
| SCHEMBL12619955 | 0.65 | ALDH1A1 (0.48) | NPC1NPSR1KDM4ECHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115353523-A | Synthesis method of compound containing high-activity cyanomethyl | 吉林大学 | 2022-11-18 | — | — | CN | claimed |
| CN-115353523-A | Synthesis method of compound containing high-activity cyanomethyl | 吉林大学 | 2022-11-18 | — | — | CN | disclosed |
| WO-2021114207-A1 | PRODUCTION OF BENZENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2021-06-17 | — | — | WO | disclosed |
| US-9206128-B2 | Modulators of methyl modifying enzymes, compositions and uses thereof | CONSTELLATION PHARMACEUTICALS, INC. (US) | 2015-12-08 | — | — | US | disclosed |
| US-20140288123-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS, INC. | 2014-09-25 | — | — | US | disclosed |
| EP-2780014-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | Constellation Pharmaceuticals, Inc. (US) | 2014-09-24 | — | — | EP | disclosed |
| WO-2013075083-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | CONSTELLATION PHARMACEUTICALS (US) | 2013-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288123-A1 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | TET1, TET3, EHMT2 | NPC1 4022/4885NPSR1 4719/4885KDM4E 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.